KILITCH DRUGS (INDIA)
Back to Income Statement
|
KILITCH DRUGS (INDIA) Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹27 Cr | ₹15 Cr | ₹10 Cr | ₹7.37 Cr | ₹3.67 Cr |
What is the latest Consolidated Net Profit of KILITCH DRUGS (INDIA) ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹27 Cr |
| Mar2024 | ₹15 Cr |
| Mar2023 | ₹10 Cr |
| Mar2022 | ₹7.37 Cr |
| Mar2021 | ₹3.67 Cr |
How is Consolidated Net Profit of KILITCH DRUGS (INDIA) Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹27 Cr | 82.87 | |
| Mar2024 | ₹15 Cr | 39.75 | |
| Mar2023 | ₹10 Cr | 41.82 | |
| Mar2022 | ₹7.37 Cr | 100.68 | |
| Mar2021 | ₹3.67 Cr | - | |
Compare Consolidated Net Profit of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹644.0 Cr | 2.3% | 1.6% | -11.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,678.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | 2.3% |
1.6% |
-11.8% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses